In Vitro Evaluation of Biocompatibility for Injectable Poly (ε-caprolactone)-Pluronic F127 (PCL-Pluronic) Hydrogel

Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 1, 2011, Pages 16-22

  Choi, Jeong Yeon ^a,b   Lim, Hyun Ju ^a   Haider Abdi, Syed Izhar ^a,b   Chung, Ho Yun ^a,b   Lim, Jeong Ok ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

caprolactone; Amniotic fluid stem cell; Cell therapy; Hydrogel; Injectable; Pluronic F127; Thermosensitive

Indexed keywords

AMNIOTIC FLUID STEM CELLS; CAPROLACTONE; CELL THERAPY; INJECTABLE; PLURONIC F-127; THERMO SENSITIVE;

BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; COPOLYMERS; PHASE DIAGRAMS; STEM CELLS; TISSUE REGENERATION;

HYDROGELS;

EID: 84862789373     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. AS Hoffman, Hydrogels for biomedical applications, Adv Drug Del Rev, 43, 3 (2002).
2. M Hrubý, Ko ák and K Ulbrich, Polymeric micellar pHsensitive drug delivery system for doxorubicin, J Control Rel, 103, 137 (2005).
3. MS Kim, KS Seo, G Khnag, et al., Thermoreversible gelation of poly(ethylene oxide) biodegradable polyesters, J Polym Sci Polym Chem, 37, 751 (1999).
4. ER Gariepy, JC Leroux, In situ-forming hydrogels-review of themperature-sensitive system, Eur J Pharm Biopharm, 58, 409 (2004).
5. B Jeong, YH Bae, DS Lee, et al., Biodegradable block copolymers as injectable drug-delivery systems, Nature, 388, 860 (1997).
6. WE Hennink, CF Van Nostrum, Novel crosslinking methods to design hydrogels, Adv Drug Del Rev, 54, 13 (2002).
7. B Jeong, YK Choi, YH Bae, et al., New biodegradable polymers for injectable drug delivery systems, J Control Rel, 62, 109 (1999).
8. J Kopecek, JY Yang, Review-hydrogels as smart biomaterials, Polymers International, 58, 1078 (2007).
9. CB Packhaeuser, J Schnieders, CG Oster, et al., In situ forming parenteral drug delivery system: an overview, Eur J Pharm Biopharm, 58, 445 (2004).
10. R Yoshida, K Sakai, T Okano, et al., Pluronic drug delivery systems using hydrogels, Adv Drug Deliv Rev, 11, 85 (1993).
11. B Jeong, SW Kim, YH Bae, Thermosensitive sol-gel reversible hydrogels, Adv Drug Deliv Rev, 54, 37 (2002).
12. LE Bromberg, ES Ron, Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery, Adv Drug Deliv Rev, 31, 197 (1998).
13. MR Kim, TG Park, Temperature-responsive and degradable Hyaluronic acid/Pluronic composite hydrgels for controlled release of human growth hormone, J Control Rel, 80, 69 (2002).
14. T lnoue, G Chen, K Nakamae, et al., Temperature sensitivity of a hydrogel network containing different LSCT oligomers grafted to the hydrogel backbone, Polymer Gels Network, 5, 561 (1997).
15. CB Liu, CY Gong, YF Pan, et al., Synthesis and characterization of a thermosensitive hydrogle based on biodegradable amphiphilic PCL-pluronic (L35)-PCL block copolymers, Colloids and Surfaces A : Physicochem Eng Aspects, 302, 430 (2007).
16. W Brown, K Schillen, M Almgren, et al., Micelle and gel formation in a poly(ethylene oxide)/poly(propylene oxide)/ poly(ethylene oxide) triblock co-polymer in water solution. Dynamic and static Light scattering and oscillatory shear measurements, J Phys Chem, 95, 1850 (1991).
17. JC Ha, SY Kim YM Lee, Poly(ethylene oxide)-poly (propylene oxide)-poly(ethylene oxide) (pluronic)/poly(caprolactone) (PCL) amphiphilic block copolymeric nanospheres. I. Preparation and characterization, J Control Rel, 62, 381 (1999).
18. XY Xiong, KC Tam, LH Gan, Synthesis and aggregation behavior of pluronic F127/poly(lactic acid) block copolymers in aqueous solutions, Macromolecules, 36, 9979 (2003).
19. XY Xiong, KC Tam, LH Gan, Hydrolytic degradation of pluronic F127/poly(lactic acid)block copolymer nanoparticles, Macromolecules, 37, 3425 (2004).
20. XJ Loh, KBC Sng, J Li, Synthesis and water-swelling of thermoresponsive poly(ester urethanes) containing poly(caprolactone), poly-(ethylene glycol) and poly(propylene glycol), Biomaterials, 29, 3185 (2008).
21. B Jeong, TH Bae, SW Kim, Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers, J Control Rel, 63, 155 (2000).
22. S Zhou, X Deng, H Yang, Biodegradable poly (carprolactone)- poly (ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system, Biomaterials, 24, 3563 (2003).
23. PD Coppi, G Gartsch Jr, MM Siddiqui, et al., Isolation of amniotic stem cell lines with potential for therapy, Nat Biotech, 25, 100 (2007).
24. PD Coppi, A Callegari, A Chiavegato, et al., Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells, J Urol, 177, 369 (2007).
25. L. Perin, S. Giuliani, D. Jin, et al., Renal differentiation of amniotic fluid stem cells, Cell Prolif, 40, 936 (2007).
26. SF Khattak, SR Bhatia, SC Roberts, Pluronic F127 as a cell encapsulation material: utilization of membrane-stabilizaing agents, Tissue Eng, 11, 974 (2005).